Skip to content

Clinical trials

Phase 2 Neurodegenerative Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Phase: Phase 2 Country / region: France Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20131
20171
20181
20191
20224
20232
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting2
Recruiting2
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
MapLight Therapeutics2
Novartis2
Novartis Pharmaceuticals2
Affiris AG1
Alkahest, Inc.1
Alterity Therapeutics1
Bial R&D Investments, S.A.1
GenSight Biologics1
Genentech, Inc.1
InFlectis BioScience1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases16
Alzheimer Disease7
Central Nervous System Diseases7
Brain Diseases6
Dementia6
Nervous System Diseases6
Mental Disorders5
Neurocognitive Disorders5
Tauopathies4
Parkinson Disease3

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.